Read More Pharma Industry News Teva and Regeneron report positive Phase 3 results for Fasinumab in osteoarthritis pain management Teva Pharmaceutical Industries and Regeneron Pharmaceuticals have announced successful outcomes from their phase 3 study of fasinumab, a… bypharmanewsdailyAugust 19, 2018
